William R. Perrault - Concepedia

Author

William R. Perrault

Pfizer (United States)

Also Known As

W. Perrault, W. R. PERRAULT, William R Perrault, William R. Perrault

Publications

233

Citations

H-Index

Concepts

All Affiliations

Pfizer (United States)W.E. Upjohn Institute for Employment Research

About

William R. Perrault is an author at Pfizer (United States) specializing in pharmacology, drug discovery, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	144
2	Natural Sciences	4	4	85
3	Biomolecular Engineering	4	4	148
4	Engineering	3	3	70
5	Biochemistry	3	3	71

William R. Perrault

Publications

231

Citations

H-Index

Page 1

	Year	Citations
The Synthesis of <i>N</i>-Aryl-5(<i>S</i>)-aminomethyl-2-oxazolidinone Antibacterials and Derivatives in One Step from Aryl Carbamates William R. Perrault, Bruce A. Pearlman, Delara B Godrej, Organic Process Research & Development Medicinal ChemistryDerivativesMedicineAntibacterial AgentAryl Carbamates	2003	76
Solvent and in situ catalyst preparation impacts upon Noyori reductions of aryl-chloromethyl ketones: application to syntheses of chiral 2-amino-1-aryl-ethanols Steven P. Tanis, Bruce R. Evans, James A. Nieman, Tetrahedron Asymmetry Noyori ReductionsEngineeringAryl-chloromethyl KetonesCatalytic SynthesisSitu Catalyst Preparation	2006	41
A Convergent, Scalable Synthesis of HIV Protease Inhibitor PNU-140690 Kristina S. Fors, James R. Gage, Richard F. Heier, The Journal of Organic Chemistry Bioorganic ChemistryMolecular BiologyAntiviral DrugPharmaceutical ChemistryScalable Synthesis	1998	36
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase Steven P. Tanis, Joseph W. Strohbach, Timothy T. Parker, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryMedicineNatural SciencesAntiviral Drug Development	2010	18
Production Scale Synthesis of the Non-Nucleoside Reverse Transcriptase Inhibitor Atevirdine Mesylate (U-87,201E) William R. Perrault, K. Paul Shephard, Lori A. LaPean, Organic Process Research & Development EngineeringAtevirdine MesylateMolecular BiologyOrganic ChemistryAntiviral Drug	1997	17
Stereodivergent synthesis of sulfoxide-containing oxazolidinone antibiotics James R. Gage, William R. Perrault, Toni‐Jo Poel, Tetrahedron Letters PharmacologySynthetic ChemistryStereoselective SynthesisStereodivergent Synthesis	2000	17
Development of a Pilot-Scale Preparation of <i>N</i>-[[(5S)-3-[4-(1,1-Dioxido-4- thiomorpholinyl)-3,5-difluorophenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, PNU-288034, an Oxazolidinone Antibacterial Agent Cuong V. Lu, Jiong J. Chen, William R. Perrault, Organic Process Research & Development Bioorganic ChemistryOrganic ChemistryAntimicrobial ChemotherapyMedicinal ChemistryDouble Michael Addition	2006	14
An environmentally friendly and cost effective synthesis of estradiol featuring two novel reagents: Si(0)/KF and PMHS/hexamethyldisiloxane/pTSA Chongsoo Lim, Gerald N. Evenson, William R. Perrault, Tetrahedron Letters Chemical EngineeringEngineeringGreen ChemistryCost Effective SynthesisSustainable Synthesis	2006	12

Page 1